Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -94.50% is 12% below its 5-year average of -84.21%, near the high end of its 5-year range (-444.73%–-17.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.92% below its 12-month average of -90.93%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -94.50%.
RETURN ON EQUITY (ROE)
-94.50%
RETURN ON EQUITY (ROE) AVG TTM
-90.93%
RETURN ON EQUITY (ROE) AVG 3Y
-111.11%
RETURN ON EQUITY (ROE) AVG 5Y
-84.21%
RETURN ON EQUITY (ROE) AVG 10Y
-73.83%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.92%
CURRENT VS 3Y AVG
+14.95%
CURRENT VS 5Y AVG
-12.22%
CURRENT VS 10Y AVG
-27.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.56%
median of 737 covered companies
CURRENT VS SECTOR MEDIAN
-127.38%
vs the sector median at left
Rhythm Pharmaceuticals, Inc.
Market Cap
$6.19B
Return on Equity (ROE)
-94.50%
TTM Avg
-90.93%
3Y Avg
-111.11%
5Y Avg
-84.21%
Market Cap
$6.02B
Return on Equity (ROE)
-15.40%
TTM Avg
-48.41%
3Y Avg
-63.30%
5Y Avg
-53.67%
Market Cap
$5.91B
Return on Equity (ROE)
-39.33%
TTM Avg
-54.18%
3Y Avg
-65.89%
5Y Avg
-59.69%
Market Cap
$5.90B
Return on Equity (ROE)
20.38%
TTM Avg
5.87%
3Y Avg
3.40%
5Y Avg
3.36%
Market Cap
$6.49B
Return on Equity (ROE)
476.51%
TTM Avg
2.59%
3Y Avg
-115.75%
5Y Avg
-71.67%
Market Cap
$6.50B
Return on Equity (ROE)
-73.19%
TTM Avg
-58.90%
3Y Avg
-54.50%
5Y Avg
-46.46%
Market Cap
$6.51B
Return on Equity (ROE)
20.99%
TTM Avg
25.07%
3Y Avg
24.12%
5Y Avg
13.08%
Market Cap
$6.52B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$5.82B
Return on Equity (ROE)
-396.09%
TTM Avg
-131.69%
3Y Avg
-109.48%
5Y Avg
-82.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | $6.19B | -94.50% | -90.93% | -111.11% | -84.21% |
| GRAIL Inc. (GRAL)vs › | $6.02B | -15.40% | -48.41% | -63.30% | -53.67% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | -39.33% | -54.18% | -65.89% | -59.69% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.90B | 20.38% | 5.87% | 3.40% | 3.36% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 476.51% | 2.59% | -115.75% | -71.67% |
| Immunovant, Inc. (IMVT)vs › | $6.50B | -73.19% | -58.90% | -54.50% | -46.46% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 20.99% | 25.07% | 24.12% | 13.08% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.52B | -43.83% | 25.09% | 5.57% | 0.40% |
| Kodiak Sciences Inc. (KOD)vs › | $5.82B | -396.09% | -131.69% | -109.48% | -82.27% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.78B | 12.33% | 0.28% | 12.51% | -14.51% |
ROE
-94.5%
ROA
-47.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -94.50% |
| 2026-03-31 | -85.30% |
| 2025-12-31 | -72.79% |
| 2025-09-30 | -65.04% |
| 2025-06-30 | -137.04% |
| 2025-03-31 | -103.44% |
| 2024-12-31 | -158.35% |
| 2024-09-30 | -169.56% |
| 2024-06-30 | -144.53% |
| 2024-03-31 | -444.73% |
| 2023-12-31 | -108.79% |
| 2023-09-30 | -93.96% |
| 2023-06-30 | -99.97% |
| 2023-03-31 | -82.15% |
| 2022-12-31 | -68.54% |
| 2022-09-30 | -64.54% |
| 2022-06-30 | -89.83% |
| 2022-03-31 | -70.46% |
| 2021-12-31 | -24.50% |
| 2021-09-30 | -19.13% |
| 2021-06-30 | -17.16% |
| 2021-03-31 | -14.72% |
| 2020-12-31 | -80.46% |
| 2020-09-30 | -67.05% |
| 2020-06-30 | -59.46% |
| 2020-03-31 | -57.65% |
| 2019-12-31 | -50.08% |
| 2019-09-30 | -89.38% |
| 2019-06-30 | -63.35% |
| 2019-03-31 | -39.27% |
| 2018-12-31 | -30.08% |
| 2018-09-30 | -21.91% |
| 2018-06-30 | -18.08% |
| 2018-03-31 | -32.78% |
| 2017-12-31 | -23.28% |
| 2017-09-30 | -108.42% |
| 2017-06-30 | -78.06% |
| 2017-03-31 | -128.13% |
| 2016-12-31 | -376.43% |
| 2016-03-31 | -53.99% |
| 2015-12-31 | -37.50% |
| 2015-09-30 | -26.39% |
